# A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

> **NCT04586907** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 85 (actual)

## Conditions studied

- Healthy
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** LY3537021
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04586907
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-23
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2021-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04586907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04586907, "A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04586907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*